| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |